Emicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trials
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
WILEY-BLACKWELL
Abstract
Description
Keywords
Citation
WOS